JPRN-UMIN000009166已完成未知
Efficacy and safety of repaglinide on glycemic control in diabetic patients with chronic renal failure [Diamond study-2] - Efficacy of repaglinide in diabetic patients with chronic renal failure [Diamond study-2]
Diamond study group0 个研究点目标入组 20 人开始时间: 2012年10月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe liver dysfunction (AST >= 100 IU/L or ALT >= 100 IU/L) Patients with malignancy under medical treatment Patients with untreated diabetic retinopathy Patients disqualified by doctor for any reason
研究者
相似试验
已完成
不适用
the efficacy for type 2 Diabetes of Repaglinide taking twice or three times a daytype 2 diabetesJPRN-UMIN000006855Graduate School of Medicine, Yokohama City University40
已完成
4 期
A Postmarketing Clinical Study of Repaglinide in Combination with Insulin in Patients with Type 2 Diabetes MellitusType 2 diabetes mellitusJPRN-jRCT1080223173Sumitomo Dainippon Pharma Co., Ltd.117
已完成
不适用
Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients with type 2 diabetesJPRN-UMIN000034778Ichinomiyanishi Hospital60
已完成
不适用
The efficacy of GLP-1 receptor agonist on glycemic control in type 2 diabetes with inadequate DPP-4 inhibitor therapy.type 2 diabetesJPRN-UMIN000006959Department of Metabolism and Endocrinology, Juntendo Graduate University of Medicine90
已完成
不适用
Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysisType-2 diabetes mellitusJPRN-UMIN000002663ihon University School of Medicine30